Key Takeaways

  • Selling to the U.S. government faces a 'principal agent problem' where warfighters, the end-users, “almost never has budget or purchasing authority,” forcing vendors to navigate separate paths for buy-in, requirement definition, congressional funding, and identifying the ultimate buyer.
  • The current oligopoly in defense isn't organic; it was engineered. Post-Cold War, the government explicitly drove consolidation via the 'Last Supper' event, summoning CEOs to the Pentagon and signaling that many companies would go out of business without mergers to survive budget cuts.
  • New entrants, dubbed 'neo-primes,' are challenging the established order by self-funding their research and development. This bypasses the traditional reliance on government R&D contracts, allowing them to build products independently and compete directly.
  • The multi-year procurement timeline, stretching from initial warfighter approval to congressional funding, creates significant barriers to entry, favoring incumbents with deep pockets and long sales cycles, or new players willing to front the capital themselves.

The Labyrinth of Pentagon Procurement

Selling technology to the U.S. Department of Defense is less a sales process and more a bureaucratic marathon. David George, founder of Marq, detailed a system riddled with what he calls 'principal agent issues.' The core problem: the warfighter, the ultimate end-user of defense technology, "almost never has budget or purchasing authority." This disconnect means a vendor can gain enthusiastic buy-in from the troops in the field, only to find that support translates into zero actual revenue until a Byzantine sequence of steps is completed. First, that warfighter support must align with a defined government requirement. Then, the project needs to secure funding, a process that frequently means "going to Congress." George noted, even after these hurdles, "you still have to find the right buyer in the DoD." This multi-stage gauntlet from user validation to budget allocation to actual procurement can stretch for years, often without clear visibility or consistent points of contact. It’s a process David George called a "really challenging customer to work with, for decades, for a hundred different reasons."

The Engineered Oligopoly: From 'Last Supper' to Neo-Primes

For decades, the defense industrial base has been characterized by a handful of large primes. This isn't just market evolution; it was a deliberate government strategy. George recounted a pivotal event dubbed the 'Last Supper.' In the wake of the Cold War, facing significant defense budget cuts, the U.S. government convened all the defense company CEOs at the Pentagon. The message was stark: “Look to your left, look to your right. One of you is going to be out of business at least, and so we highly encourage you to consolidate.” This direct intervention reshaped the industry, creating the oligopoly we know today. The consequence was a stifled innovation ecosystem, with fewer independent companies able to absorb the risk of the protracted and uncertain government procurement cycle.

However, this engineered structure is now encountering new pressures. George highlights how "neo-primes" like Anduril are challenging this status quo. Their central insight: bypass the traditional reliance on government funding for early-stage R&D. Instead, these companies "are going to fund our own product development and then we are going to go try and just like compete in the market." By self-funding, they mitigate the 'principal agent problem' and the congressional funding delays in their early stages, allowing them to build and iterate on technology outside the immediate, restrictive bounds of government contracts. They present fully developed solutions, shortening the sales cycle once they engage with a specific DoD buyer.

Why It Matters

This insight signals a fundamental shift in capital allocation within defense tech. The rise of self-funded 'neo-primes' demands a re-evaluation of valuation multiples, rewarding companies that can demonstrate independent R&D velocity and early market traction outside traditional government contracting. For private equity and operating partners, this highlights a potential arbitrage: acquiring companies with strong, independently developed IP and then leveraging operating expertise to accelerate the complex, late-stage government procurement process. It also flags the inherent discount on assets still reliant on legacy government R&D funding, as their timelines and ultimate market access remain subject to a deeply entrenched, politically driven bureaucracy rather than purely technological merit. The "Last Supper" created an oligopoly; the 'neo-primes' are now demonstrating a viable path to erode its edges, signaling new deal flow and investment theses.